Biotech Daily Home - Biotech Daily, Daily news on ASX-listed biotechnology companies

Web Name: Biotech Daily Home - Biotech Daily, Daily news on ASX-listed biotechnology companies

WebSite: http://www.biotechdaily.com.au

ID:208393

Keywords:

Home,news,Biotech,Daily,on,biotechnology,companies,ASX,BiotechDaily,ASX,biotechn

Description:

keywords:Biotech Daily,ASX, biotechnology companies, Australia, David Langsam, stocks, shares, Australian Stock Exchange, biotechnology, newsletter
description:Biotech Daily covers the major announcements from ASX-listed biotech companies as well as developments in government policy and regulation. Published shortly after the stock market closes five days a week - excluding public holidays - Biotech Daily is the only comprehensive daily source of information on the listed biotech sector.



Biotech Daily covers the major announcements from more than 140 ASX-listed biotech companies as well as the major research institutes and developments in government policy.

Published shortly after the stock market closes five days a week - excluding public holidays - Biotech Daily is the only comprehensive daily source of information on the listed biotech sector.

The Biotech Daily Top 40 Index (BDI-40) is selected on the basis of interesting technologies, benefit to human health and investment potential. Market capitalization is important, but is not a sole arbiter.

Base-rate subscriptions are $A1600 a year (including GST in Australia).

Subscribers include biotech directors and CEOs, major pharmaceutical companies, universities, research institutes, investment houses, market analysts, retail investors, doctors, medical specialists and hospital management.

Download subscription form here

Latest News !

Biotech Call To Arms: David Blake - Update: Oct 18, 2021

Dr Boreham's Crucible: Sars-Cov-2 Tests

Dr Boreham's Crucible Takes A Trip Through The Psychedelics

Clarity $92m IPO For Cancer Radio-Pharmaceuticals

Victoria: 'Funding Returns 366% GSP, 454% Income In 10 Years'

A Year In The Grass - Medical Marijuana Review

Biotech Daily 1st Medical Marijuana Survey

CSIRO, Doherty Distance From 'Tier 1' Sars-Cov-2 Claims


September BDI-40 Down 4%, ASX200 Down 3%
Big Caps Down 8%, NBI Down 5%

Friday October 1, 2021

All indices retreated from last month’s record highs, with the Biotech Daily Top-40 Index (BDI-40) down 4.2 percent, the ASX200 down 2.7 percent, the three Big Caps down 7.6 percent and the Nasdaq Biotechnology Index (NBI) down 4.9 percent.The collective market capitalization of the three Big Caps of Cochlear, CSL and Resmed (which are not included in the BDI-40) fell 7.6 percent in September to $199,374 million, with CSL leading the pack, down 7.9 percent to $130,713 million. Resmed retreated 7.3 percent to $54,257 million - its second highest end of month valuation - while Cochlear shed 6.1 percent to $14,404 million.For the year to September 30, the BDI-40 was up 33.5 percent, the benchmark ASX200 was up 26.1 percent, the Big Caps rose 9.5 percent and the NBI was up 19.5 percent.The September BDI-40 saw a plethora of small falls and rises, but Imugene added a further $410 million to its already gravity-defying $2,212 million to close the month at $2,622 million. Pro Medicus lost $1,096 million to a market capitalization of $5,488 million.Twenty of the BDI-40 companies were up, eight by more than 10 percent, while 17 fell, with eight down by more than 10 percent.Medical Developments was the best, recovering $110 million or 42.5 percent to $369 million, followed by Prescient up $43 million in the month or 34.4 percent to a record $168 million, Imugene (18.5%), Actinogen (14.2%), Kazia (13.1%), Orthocell (11.4%), Cynata (10.7%) and Starpharma (10.4%).Osprey again led the falls, down a further $8 million or 28.6 percent to $20 million, followed by Resonance (22.6%), Proteomics (19.0%), Pro Medicus (16.6%), Telix (15.9%), Polynovo (15.1%), Dimerix (13.8%) and Universal Biosensors (11.6%).Outside the BDI-40, Atomo, Emvision, Cogstate and Anteo were resilient in September. The collective market capitalization of the 22 companies in Cannabis Corner was up 0.75 percent to $1,737 million.On the Nasdaq, both Queensland’s Protagonist and Redhill (with Australian assets) fell sharply on news that the US Food and Drug Administration had placed a hold on the former’s rusfertide (PTG-300) cancer trials; and the latter’s opaganib failed to meet its endpoints for hospitalized patients with severe Covid-19 pneumonia. Protagonist fell 63.0 percent to $1,166 million and Redhill lost 54.1 percent to $296 million. Eyepoint (formerly Psivida) looked good by retreating just 3.5 percent to $415 million.With a raft of new listings over the past year, the BDI-40 is under review – a task that no longer can be put off. Deciding who to promote is easier than deciding who to demote.Among the contenders for promotion are 4D Medical, Aroa, Atomo, Clarity, Emvision, Imagion, Imricor, Lumos, Pacific Edge and Trajan, with only three or four companies on the potential demotions list.

BDI-40 v SP ASX200 Jun 30, 2006 to Sep 30, 2021 5-Year Big Caps (Cochlear, CSL, Resmed) to Sep 30, 2021

BDI-40 ($m) v SP ASX200 – Jan 31, 2020 - Sep 30, 2021
(current, raw data)

Click here for Biotech Daily's archive

Biotech Daily Top 40 With Market Capitalization At Sep 30, 2021

* Biotech Daily editor, David Langsam, owns shares in Acrux, Actinogen, Alcidion, Alterity, Amplia, BTC Health, Clarity, Cochlear
Control Bionics, Cynata, Nanosonics, Neuren, Patrys, Polynovo, Telix and Volpara, as well as non-biotechnology stocks.
Through Australian Ethical Superannuation he has an indirect interest in a range of biotechnology companies.
These holdings are liable to change:
https://www.australianethical.com.au/personal/ethical-investing/companies-we-invest-in/.

To subscribe to Biotech Daily
click here

TAGS:Home news Biotech Daily on biotechnology companies ASX BiotechDaily ASX biotechn

<<< Thank you for your visit >>>

Biotech Daily covers the major announcements from ASX-listed biotech companies as well as developments in government policy and regulation. Published shortly after the stock market closes five days a week - excluding public holidays - Biotech Daily is the only comprehensive daily source of information on the listed biotech sector.

Websites to related :
GlamourVision

  keywords:pantyhose glamour slip hose heels lingerie art bra high-heels kardashian sarah hiland
description:The World&#39;s Most Beautiful Models!

Girls Who Code | Home

  keywords:coding for girls coding club summer coding girls code reshma saujani coding nonprofit brave not perfect
description:Learn to code! Free summe

LED Component Manufacturer--chin

  keywords:
description:
LED Component Manufacturer--chinaHangzhou Hangke Optoelectronics Co.,Ltd.is leading LED component manufacturer in china since 1

TypeLogic Home Page

  keywords:
description:

predestination.com

  keywords:
description:Forsale Lander
predestination.comThis domain is available for sale!Get a price in less than 24 hoursFill out the form below. One

Bedfordshire At War: The Home Fr

  keywords:
description:
BEDFORDSHIRE AT WAR: News from the Home FrontImage (c) artist Hugh Byrne, Shop33 and SNAPHomeLinksAbout Us Mon

Media Statements - Home

  keywords:Department of the Premier and Cabinet, Media Statements DPC Functions, Intergovernmental Policy, Guidelines and Policies, WA Government, Prem

Poetry Biz - “Jack Foley is doi

  keywords:
description:
Jack  Adelle Foley
Oakland, CA
ph:
jack@jack-adellefoley.comJack Adelle Foley News Events Adelle: Book Poems Jack: Boo

Things to do in Charleston South

  keywords:
description:Directory of the finest things to do in Charleston, South Carolina. Find hotels, restaurants, attractions, historic King street,

Flying Vet challenges South Wale

  keywords:
description:... advancing the Cause of Litigants in Person
Flying Vet challenges South Wales Police advancing the Cause o

ads

Hot Websites